Vanda Pharmaceuticals VNDA Cash Flow Statement (2010-2026)

NASDAQ VNDA
$5.43 +0.09 (+1.69%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Vanda Pharmaceuticals Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Vanda Pharmaceuticals reported cash from operations of -$31.07M and free cash flow of -$31.26M for the quarter ended Jun 2026, down 103.7% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
7.72M7.10M-6.43M2.57M3.26M6.89M3.23M1.49M0.18M-2.39M-4.15M-4.52M-5.32M-4.91M-29.47M-27.19M-22.59M-141.23M-48.57M-62.51M
Share-based CompensationStock Comp.
3.95M3.77M4.78M3.83M3.89M3.78M4.35M3.25M3.17M3.27M3.58M2.99M3.00M2.86M2.97M2.11M2.11M2.29M2.56M2.11M
Deferred Taxes
2.53M1.31M4.42M-1.87M-1.84M0.42M2.01M1.46M2.73M-7.48M-0.25M-1.23M-3.09M-1.91M-7.80M-7.97M-5.97M103.19M
Cash from OperationsCash from Ops.
9.40M26.61M4.05M5.68M12.84M9.42M31.80M-13.22M-2.05M-3.73M7.57M-6.93M-14.58M-1.82M-33.15M-15.25M-31.63M-29.42M-50.22M-31.07M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
Change in Working Capital
Change in ReceivablesChange Receivables
4.42M-9.02M-1.96M-1.62M0.59M4.07M-8.90M9.10M-4.33M4.84M2.59M5.16M0.83M4.43M-2.53M0.35M5.57M4.08M2.33M2.80M
Change in InventoryChange Inventory
0.79M0.08M1.18M0.40M1.77M1.13M-0.07M-0.14M0.55M0.43M-0.03M-0.26M0.21M0.11M1.85M0.37M-0.03M1.28M-0.29M0.10M
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
-0.03M2.18M13.43M0.31M1.34M-3.28M-10.79M-3.24M-0.28M3.33M1.17M3.14M-0.47M-2.13M5.64M11.33M-10.22M9.08M1.48M10.20M
Change in TaxesChange Taxes
Other Working Capital ChangesOther WC Changes
Investing Activities
Capital ExpendituresCapex
-0.01M0.13M0.07M0.19M0.15M0.26M0.05M0.06M0.02M0.25M0.01M0.11M0.16M0.21M0.44M0.30M0.16M0.10M0.22M0.19M
Change in Acquisitions & DivestmentsChange Acquisitions
101.24M79.41M90.08M82.45M147.34M80.00M350.39M57.09M82.00M112.11M60.50M99.00M95.95M96.61M87.67M38.00M35.57M47.00M30.45M34.00M
Cash from Investing ActivitiesCash from Investing
-16.59M-26.00M10.87M-14.59M-21.78M75.43M187.29M-190.89M35.33M-43.78M-18.22M-15.26M12.06M3.99M43.90M-15.27M21.36M44.87M20.23M33.81M
Financing Activities
Other financing activitiesOther financing
0.37M1.09M0.12M0.00M0.60M
Cash from Financing ActivitiesCash from Financing
0.37M1.04M0.12M0.00M0.60M-0.15M-1.32M-0.42M-0.52M-0.64M-0.78M-0.86M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Exchange Rate EffectFX Effect
0.04M-0.10M-0.06M0.08M0.06M0.18M0.04M-0.03M-0.12M0.15M-0.01M-0.01M0.07M-0.20M0.05M0.13M-0.18M0.02M-0.06M-0.04M
Change in Cash
-6.78M1.55M14.86M-8.70M-8.88M85.63M219.14M-204.14M33.16M-47.37M-10.66M-22.20M-2.46M1.82M9.48M-30.81M-10.96M14.83M-30.82M1.85M
Free Cash FlowFCF
9.41M26.47M3.97M5.49M12.69M9.15M31.75M-13.28M-2.07M-3.98M7.56M-7.04M-14.74M-2.03M-33.58M-15.55M-31.79M-29.52M-50.44M-31.26M
Net Cash FlowNCF
-6.82M1.65M14.91M-8.78M-8.94M85.45M219.10M-204.11M33.28M-47.52M-10.65M-22.19M-2.52M2.02M9.43M-30.95M-10.78M14.81M-30.76M1.88M